R. Kim

Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.

N. Okun, D. Chitayat, C. V. van Karnebeek, 2016, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes.

N. Okun, D. Chitayat, Isabelle De Bie, 2017, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline

M. Bernardini, L. Elit, S. Ferguson, 2021, Hereditary cancer in clinical practice.

Survival from breast cancer in women with a BRCA2 mutation by treatment

F. Couch, P. Møller, W. Foulkes, 2021, British Journal of Cancer.

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

F. Couch, O. Olopade, P. Møller, 2023, Breast Cancer Research and Treatment.